Integrated BioPharma, Inc. INBP
0.17 USD 0.00 (+2.21%)
At closeNov 6, 2026, 4:00 PM EST
0.17375 Day range 0.17375
0.14 52-week range 0.42
- YTD
- -51.74%
- 1 year
- -40.09%
Revenue & Expenses
Latest period ending Jun 30, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 | FY 2020 Jun 30, 2020 | FY 2019 Jun 30, 2019 |
|---|---|---|---|---|---|
| 50.67M | 56.25M | 63.56M | 52.77M | 49.98M | |
| 4.06M | 6.55M | 9.48M | 6.73M | 6.22M | |
| 120.00K | 2.75M | 5.78M | 3.26M | 2.70M | |
| -34.00K | 3.84M | 8.01M | 4.11M | 1.69M |
Balance sheet
| Fiscal year | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 | FY 2020 Jun 30, 2020 | FY 2019 Jun 30, 2019 |
|---|---|---|---|---|---|
| 1.32M | 331.00K | 210.00K | 402.00K | 475.00K | |
| 25.43M | 25.25M | 25.44M | 22.94M | 19.79M | |
| 6.57M | 6.67M | 11.11M | 16.88M | 17.90M | |
| 2.67M | 2.06M | 6.00M | 11.13M | 12.89M | |
| 18.86M | 18.57M | 14.33M | 6.07M | 1.89M |
Cash flow
| Fiscal year | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 | FY 2020 Jun 30, 2020 | FY 2019 Jun 30, 2019 |
|---|---|---|---|---|---|
| 1.23M | 4.09M | 3.05M | 1.34M | 328.00K | |
| -111.00K | -465.00K | -199.00K | -110.00K | -422.00K | |
| -136.00K | -3.50M | -3.04M | -1.30M | 341.00K | |
| -115.00K | -465.00K | -295.00K | -211.00K | -414.00K | |
| 985.00K | 121.00K | -192.00K | -73.00K | 247.00K |